# Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

Study · id `cardio:ct-nct03821623` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03821623](<https://clinicaltrials.gov/study/NCT03821623>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03821623

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 118 participants.

## Technical summary

Registry record NCT03821623. Randomized; triple masking; primary purpose treatment. Start 2019-05-10 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 118 participants (planned count; ClinicalTrials.gov record NCT03821623, source copy `cardio:ctgov-nct03821623-2026-10-02`, retrieved 2026-10-26)
- Started: 2019-05-10 (actual) (ClinicalTrials.gov record NCT03821623, source copy `cardio:ctgov-nct03821623-2026-10-02`, retrieved 2026-10-26)
- Primary completion: 2027-09-01 (anticipated) (ClinicalTrials.gov record NCT03821623, source copy `cardio:ctgov-nct03821623-2026-10-02`, retrieved 2026-10-26)
- Completion: 2027-10-01 (anticipated) (ClinicalTrials.gov record NCT03821623, source copy `cardio:ctgov-nct03821623-2026-10-02`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03821623, source copy `cardio:ctgov-nct03821623-2026-10-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03821623-2026-10-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- Condition: Hypertension
- Condition: Aging
- Intervention (Drug): Nicotinamide riboside
- Intervention (Other): Placebo
- Lead sponsor: Douglas Seals
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: b0fee8bdfd008d830eae5a094d1189de2d185baeebc5c682dfcf26d92ef6d627
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
